The most effective weight loss medications available right now are prescription drugs, not supplements you can buy off the shelf. The newest injectable medications produce average weight loss of 15% to nearly 19% of body weight, while older oral pills typically deliver 4% to 9% beyond what diet and exercise alone achieve. What works best for you depends on your health profile, your budget, and whether you qualify for a prescription.
Prescription Medications Are the Most Effective Option
The FDA has approved several medications specifically for chronic weight management. To qualify, you generally need a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition like high blood pressure or type 2 diabetes. These aren’t short-term fixes. They’re designed for ongoing use alongside changes to diet and physical activity.
Current clinical guidelines from the American Diabetes Association now recommend offering weight loss medication as part of initial treatment for obesity, not as a last resort after other approaches have failed. That’s a significant shift from how these drugs were viewed even five years ago.
GLP-1 and Dual-Action Injectables
The medications generating the most attention are a class of drugs that mimic gut hormones to reduce appetite and slow digestion. They’re delivered as weekly injections, not pills, but they dominate any honest conversation about effective weight loss medications.
Semaglutide (sold as Wegovy) produced an average body weight loss of 15.6% over 72 weeks in clinical trials at its standard dose. A higher dose currently in trials pushed that to 18.7%. Tirzepatide (sold as Zepbound) works on two gut hormone pathways instead of one and has shown similar or greater results in head-to-head comparisons. Both are approved for adults and children 12 and older.
The injection itself goes into the fatty tissue just under the skin, not into a muscle or vein, and most people report little to no pain. You pick one day a week and that’s your only dose. The main trade-off is side effects: nausea, vomiting, diarrhea, and loss of appetite are common, especially during the first weeks as your dose increases. These typically improve over time. People with a personal or family history of a type of thyroid cancer called medullary thyroid carcinoma should not take any of these medications.
Prescription Pills You Take by Mouth
If you specifically want a pill rather than an injection, several FDA-approved oral options exist. They produce less dramatic weight loss than the injectables but are still meaningfully more effective than lifestyle changes alone.
Phentermine-topiramate (Qsymia) is the strongest oral option. Clinical trials lasting up to a year found average weight loss ranging from 6.7% at the lowest dose to 8.9% at the recommended dose, beyond what placebo groups lost. It’s approved for adults and children 12 and older but isn’t appropriate for people with glaucoma or an overactive thyroid.
Naltrexone-bupropion (Contrave) combines two medications that work on brain pathways involved in appetite and cravings. It produced an average of 4% weight loss over placebo at one year, with 42% of people losing at least 5% of their body weight compared to 17% on placebo. It’s not safe for people with uncontrolled high blood pressure, a history of seizures, or eating disorders like anorexia or bulimia. Anyone who frequently uses opioid pain medications also cannot take it.
Orlistat (Xenical) works differently from the other options. Instead of affecting appetite, it blocks about 25% of the fat you eat from being absorbed. That undigested fat passes through your digestive system, which is why the most common side effects are oily stools, gas, and urgent bowel movements. In trials, people taking orlistat lost an average of 10% of their body weight at one year, compared to 6% for those on placebo.
An oral version of a GLP-1 medication also exists, though it requires a strict routine: you take it first thing in the morning with only plain water, then wait at least 30 minutes before eating, drinking coffee or tea, or taking other medications. Anything else can interfere with absorption.
The Only Over-the-Counter Option With FDA Approval
Alli is a lower-dose version of orlistat that you can buy without a prescription. It uses the same fat-blocking mechanism as prescription orlistat but at half the strength. People who combined Alli with a calorie-restricted diet and regular exercise lost an average of 5.7 extra pounds over one year compared to people who only dieted and exercised. In some studies, more than 40% of Alli users lost at least 5% of their body weight within a year.
Those results are modest. But Alli is the only weight loss product on store shelves that has been through rigorous FDA review for both safety and effectiveness. Everything else in the supplement aisle operates under very different standards.
Why Supplements Don’t Measure Up
Dietary supplements marketed for weight loss are not required to prove they work before being sold. The NIH Office of Dietary Supplements has reviewed the evidence for dozens of popular ingredients, and the results are consistently underwhelming.
Green tea extract, one of the most widely promoted options, shows at best a “possible modest effect on body weight” across multiple clinical trials. It also carries safety concerns, including reports of liver damage with concentrated extract forms. Glucomannan, a fiber supplement frequently marketed as a fat blocker, showed “little to no effect on body weight” in clinical trials, and tablet forms have caused esophageal obstructions. The pattern repeats across most popular supplement ingredients: the marketing far outpaces the evidence.
This doesn’t mean every supplement is dangerous, but spending money on unproven products delays access to treatments that actually work. If you’re serious about pharmacological help with weight loss, a prescription medication with clinical trial data behind it will deliver more predictable results.
Cost and Insurance Coverage
The biggest barrier to the most effective medications is cost. Without insurance, GLP-1 and dual-action injectables can run over $1,000 per month. Coverage varies widely by insurer and plan. Many private insurers now cover these medications for people who meet BMI criteria, but some still exclude weight loss drugs entirely.
Medicare recently launched a GLP-1 bridge program with specific eligibility rules. You may qualify if you have a BMI of 35 or higher, or a BMI of 30 or higher with conditions like uncontrolled high blood pressure, heart failure, or kidney disease. People with a BMI of 27 or higher can qualify with a history of heart attack, stroke, peripheral artery disease, or pre-diabetes. All coverage requires a prior authorization from your provider confirming you’re also making lifestyle changes.
Older oral medications like phentermine-topiramate and naltrexone-bupropion are significantly cheaper, especially in generic forms. Alli costs roughly $30 to $60 per month out of pocket. For many people, the practical choice comes down to balancing effectiveness against what they can realistically afford and access.
How Results Compare Across Medications
To put the numbers side by side over roughly one year of use:
- Tirzepatide (Zepbound): approximately 15% to 21% body weight loss in trials, depending on dose
- Semaglutide (Wegovy): 15.6% to 18.7% body weight loss, depending on dose
- Phentermine-topiramate (Qsymia): 6.7% to 8.9% beyond placebo
- Orlistat (Xenical): roughly 4% beyond placebo
- Naltrexone-bupropion (Contrave): 4% beyond placebo
- Alli (OTC orlistat): about 2.5% beyond diet and exercise alone
These are averages. Individual results vary based on starting weight, how well you tolerate the medication, adherence to dosing, and the dietary and activity changes you make alongside it. A 15% weight loss for someone who weighs 250 pounds translates to about 37 pounds, which is enough to meaningfully improve blood pressure, blood sugar, joint pain, and sleep quality. Even a 5% loss, the threshold most clinical trials use, produces measurable health benefits.
Weight loss medications also tend to work best when you stay on them. Most clinical trials show weight regain after stopping, which is why current guidelines frame these as long-term treatments rather than temporary courses. That’s an important factor when choosing a medication: you need something you can tolerate, afford, and maintain over years, not just months.